Related Experiment Video
Updated: Jul 10, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Depression, antidepressant medication, and functioning outcomes among pregnant women
Sheila M Marcus1, Heather A Flynn
1Department of Psychiatry, University of Michigan Depression Center, University of Michigan Medical School, Ann Arbor, MI, USA. smmarcus@umich.edu
Objectives:
To describe prenatal patterns of antidepressant use and their relationship to depression in pregnancy.
Methods:
A total of 276 high risk women completed a structured clinical interview to investigate use of antidepressant medication.
Results:
Of the women interviewed, 13% (n=36) reported current use of antidepressant medication; there were no differences in depression or health functioning outcomes between women taking antidepressants and those not using them.
Conclusions:
Monitoring the depressive symptoms of women using pharmacotherapy during pregnancy is important to optimize their treatment.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Overview
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Depression: Overview
Depressive Disorders: MDD and Dysthymia
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
